An antagonist of the chemokine receptor CXCR4 induces mitotic catastrophe in ovarian cancer cells
Publication in refereed journal


Times Cited
Altmetrics Information
.

Other information
AbstractThe chemokine receptor CXCR4 is expressed by malignant cells in ovarian cancer and is implicated in their growth and spread. We report here a unique mechanism of action of a small peptide antagonist of CXCR4 on ovarian cancer cells: induction of cell death by mitotic catastrophe. CTCE-9908 inhibited ovarian cancer cell migration to CXCL12, but on longer incubation, caused cell death in CXCR4-positive cells. CTCE-9908 did not cause apoptosis or cellular senescence, but induced multinucleation, G
2-M arrest, and abnormal mitosis in ovarian cancer cells. This suggests that cell death was caused by mitotic catastrophe. Using microarray and Western blot analysis, we showed that CTCE-9908 deregulated DNA damage checkpoint proteins and spindle assembly checkpoint proteins at G
2-M phases of the cell cycle. Combination treatment of CTCE-9908 and the drug paclitaxel led to an additive cytotoxicity that also involved mitotic catastrophe. We conclude that CTCE-9908 has a unique mechanism of action in ovarian cancer cells that seems to be CXCR4 specific. © 2009 American Association for Cancer Research.
All Author(s) ListKwong J., Kulbe H., Wong D., Chakravarty P., Balkwill F.
Journal nameMolecular Cancer Therapeutics
Year2009
Month7
Day1
Volume Number8
Issue Number7
PublisherAmerican Association for Cancer Research
Place of PublicationUnited States
Pages1893 - 1905
ISSN1535-7163
LanguagesEnglish-United Kingdom

Last updated on 2020-10-10 at 01:00